U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
larcaviximab [INN]
Preferred Name English
LARCAVIXIMAB
INN   USAN  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(EBOLAVIRUS GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL C4G7 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C4G7 .KAPPA.-CHAIN, DIMER
Common Name English
ZMAP COMPONENT C4G7
Brand Name English
ZMAPP COMPONENT C4G7
Brand Name English
C4G7
Code English
Larcaviximab [WHO-DD]
Common Name English
LARCAVIXIMAB [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 440914
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
Code System Code Type Description
USAN
DE-21
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
PRIMARY
FDA UNII
181UPT812X
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
PRIMARY
SMS_ID
300000005760
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
PRIMARY
CAS
1792982-56-9
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
PRIMARY
INN
10537
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
PRIMARY
NCI_THESAURUS
C166475
Created by admin on Tue Apr 01 16:21:51 GMT 2025 , Edited by admin on Tue Apr 01 16:21:51 GMT 2025
PRIMARY
ACTIVE MOIETY
LARCAVIXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966